The cognitive fitness of President of the United States Donald Trump and the ethics of his cognitive evaluation have been the topic of intense discussion among both the general public and medical professionals in recent months.
dents of the United States have undergone routine yearly medical assessments during their tenure in office. On January 16, 2018, the physician to the president, Rear Admiral Ronny Jackson, MD, held a press briefing on President Trump's first such assessment, which included the Montreal Cognitive Assessment (MoCA), an extensively validated screening tool for mild cognitive impairment in older individuals. 2 Jackson's announcement was notable because President Trump is thought to be the first President of the United States to undergo formal cognitive evaluation while in office.
In the days immediately after this announcement, a large spike occurred in web searches for the term Montreal Cognitive Assessment. Details of the test were widely reported in mainstream media, with several large news networks explicitly inviting members of the general public to undertake the test themselves. 3, 4 Because several studies have pointed to the presence of a learning effect in those who undergo repetitive longitudinal testing, 5, 6 we sought to characterize the reporting on the MoCA after Jackson's announcement and to ascertain which test details were disseminated to the public. (Figure) .
Methods
Discussion | The announcement of President Trump's cognitive evaluation prompted considerable public interest in the MoCA.
More than half of all recovered news articles presented contents of the test, and 1 in 6 directly invited readers to undertake it. The result of this sudden and rapid dissemination of the MoCA's contents is not immediately apparent; however, given ongoing interest in age-associated cognitive function, public awareness of specific cognitive tests, such as the MoCA, may continue to increase. It is possible that the MoCA's applicability may be compromised in individuals exposed to its contents via such mainstream media reporting. This presents a problem for clinicians, because the presence of a learning effect could result in decreased sensitivity, eroding the MoCA's chief usefulness in identifying patients with mild cognitive impairment. Future research is warranted to validate test performance in populations with direct exposure to the questionnaire's content or grading scheme.
In the meantime, clinicians assessing patients with the MoCA should be aware of this potential exposure to the test and should therefore consider routinely inquiring whether a patient has previously been exposed to the MoCA. As most news articles published version 1, using alternative versions 2 or 3 of the MoCA in formal clinical settings among preexposed patients may serve as a mitigation strategy. Author Affiliations: Department of Medicine, University of Toronto,
